| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Agresta Samuel is a Chief Medical Officer at Foghorn Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2023 | FHTX Foghorn Therapeutics Inc. | Chief Medical Officer | Sale+OE | 311,297 | $8.25 | $2,568,200.25 | -100% | -56.0% | -31.1% |